ORMP - Oramed Pharmaceuticals Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.41 0.19 (7.88%) --- --- 0.0 (0.0%) --- 0.19 (7.88%) --- ---

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.32
Diluted EPS:
0.31
Basic P/E:
8.125
Diluted P/E:
8.3871
RSI(14) 1m:
40.0
VWAP:
2.6
RVol:

Events

Period Kind Movement Occurred At

Related News